Today: 19 May 2026
ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech
23 February 2026
2 mins read

ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

Sydney, Feb 24, 2026, 04:18 AEDT — Premarket

  • ASX 200 futures suggested a muted open, following Monday’s drop.
  • Tariff jitters hammered risk appetite, leaving banks and growth stocks absorbing most of the blow.
  • Australia’s January inflation figures land Wednesday, and traders are on alert.

Australian shares looked likely to start lower Tuesday, as futures on the main index traded near 8,988—roughly 0.4% under Monday’s closing level. These contracts allow investors to take a view on the index ahead of the session’s open.

The S&P/ASX 200 slipped 55.4 points on Monday, losing 0.61% to finish at 9,026 as U.S. tariff uncertainty weighed on the market. After the U.S. Supreme Court blocked President Donald Trump’s emergency tariffs, Trump pivoted to a 10% global tariff and hinted at a possible 15% rate—though details on timing and coverage stayed murky. “Trump headlines equal volatility,” said Mark Gardener, CEO at MPC markets, but he noted that earnings could provide some support. Indo Premier

This matters right now because Australia’s market remains tilted—on one end, expensive growth stocks; on the other, commodity defensives. With trade policy shifting day by day, investors usually dump risk before sorting through the details, and the ASX stands out as a clear barometer of that impulse.

Resources stocks led gains on Monday as investors shifted into so-called “safe-haven” plays—assets considered more stable when markets get shaky. The Gold Sub-Index jumped 4.1%, outpacing a 1.2% lift for the broader resources index. Growth names didn’t fare well: information technology tumbled 4.5%, healthcare was down 2.4%. Megaport plunged 17.5%, Pro Medicus lost 8.9%, and both WiseTech Global and Technology One shed 5.2%. On the flip side, Reece surged 13.9% after surpassing EBIT forecasts. Nuix soared 15.1%, swinging to a profit. Losses included Austal, which fell 11.0%, and Lendlease, down 7.2%. Market Index

The Australian dollar slipped 0.2% late Monday to roughly 70.68 U.S. cents. Spot gold picked up 1.1%, landing at $5,159 an ounce. Brent crude eased 1.3%, trading at $70.84 a barrel. Bitcoin dropped 3.7%, changing hands at $65,080.

With reporting season in full swing, stocks are bouncing around, particularly when outlooks are vague or cash-flow hopes look shaky. All that turbulence can obscure the index’s broader direction—until one-sided selling hits the usual overowned names and the move gets magnified.

The risk cuts both ways. Should tariff rhetoric shift toward actual policy, or spark retaliatory moves, pressure could linger on banks and high-multiple stocks. And that so-called “safe-haven” move into gold names? It can snap back fast if it morphs into a momentum play.

Tuesday brings focus on whether resources can keep their early gains when the rest of the market gets going, and if tech’s slump drags down other growth areas that managed to stay afloat Monday.

Traders are watching Wednesday for the next big domestic signal, when the Australian Bureau of Statistics will publish January CPI data at 11:30 a.m. AEDT. This inflation print regularly shapes Reserve Bank of Australia policy forecasts.

For now, tariff news and upcoming earnings responses are set to drive market direction.

Stock Market Today

  • LeMaitre Q1 Performance Trails Surgical Equipment Sector Leaders
    May 19, 2026, 5:33 AM EDT. LeMaitre (NASDAQ:LMAT) reported Q1 revenue of $66.55 million, up 11.2% year-on-year but missed the mark relative to analyst estimates and offered weaker full-year guidance than peers. Despite beating earnings per share (EPS) estimates for the upcoming quarter, LMAT's stock fell 10%, trading at $100.83. In contrast, sector leader Intuitive Surgical (NASDAQ:ISRG) delivered a 23% revenue increase to $2.77 billion, surpassing expectations by 5.8%, driven by its robotic-assisted surgical systems business. The surgical equipment and consumables sector as a whole beat revenue estimates by 2.7% for Q1, with stocks rising an average of 6.4%. Industry growth is underpinned by aging populations and expanding use of AI and robotics, although challenges remain around R&D costs, regulatory compliance, pricing pressures, and potential supply chain issues.

Latest articles

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.

Popular

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

19 May 2026
NextEra Energy agreed to acquire Dominion Energy in a $66.8 billion all-stock deal, sending Dominion shares up 9.4% to $67.56 while NextEra fell 4.6%. Dominion holders would get 0.8138 NextEra share per Dominion share and a $360 million cash payment. The deal requires multiple regulatory approvals. Dominion’s Coastal Virginia Offshore Wind project remains a focus after cutting costs to $11.4 billion.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
Next Story

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

Go toTop